 | • レポートコード：B-MOR-08564 • 出版社/出版日：Mordor Intelligence / 2018年5月1日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・製薬 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、無菌試験の世界市場について調べ、無菌試験の世界規模、市場動向、市場環境、製品種類別（キット・試薬、計測器、サービス）分析、試験種類別（膜ろ過、直接法、その他）分析、用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・無菌試験の世界市場インサイト ・無菌試験の世界市場環境 ・無菌試験の世界市場動向 ・無菌試験の世界市場規模 ・無菌試験の世界市場規模：製品種類別（キット・試薬、計測器、サービス） ・無菌試験の世界市場規模：試験種類別（膜ろ過、直接法、その他） ・無菌試験の世界市場規模：用途別 ・無菌試験の世界市場：地域別市場規模・分析 ・無菌試験の北米市場規模・予測 ・無菌試験のアメリカ市場規模・予測 ・無菌試験のヨーロッパ市場規模・予測 ・無菌試験のアジア市場規模・予測 ・無菌試験の日本市場規模・予測 ・無菌試験の中国市場規模・予測 ・無菌試験のインド市場規模・予測 ・無菌試験の韓国市場規模・予測 ・関連企業情報・競争状況 |
The Sterility Testing Market is expected to witness a CAGR of 12.5%, during the forecast period. The key players in the market are focusing on the product launches to strengthen their foothold in the market.
Increase Number of Drug Launches
The number of drug approvals and new drug launches in North America is increasing over the years. In 2015, FDA Center for Drug Evaluation and Research has approved around 45 novel drugs as new molecular entities under the New Drug Applications (NDAs). The statistics shows that the number of the new drug launches is increasing over the years, which is likely to impact positively on the growth of sterility testing market.
The other factors also include increasing R&D in life science research and rise in demand for sterilized products and their exclusivity in the healthcare industry.
Stringent Regulatory Framework
The sterility testing market has stringent regulatory frameworks, which lead to the lengthy approval process of the drugs, which causes huge capital investment from key players in stringent regulatory device approval process. Therefore, due to the stringent regulatory framework the market is likely to get restrained.
The high degree of market consolidation is also a major factor, which is restraining the growth of this market.
Asia Pacific is expected to dominate the Market
Sterility testing market is being dominated by North America, which is followed by Europe and Asia. The Asian market will witness the highest growth in the coming future, primarily due to the increasing expenditure on life science research in the region.
Key Developments in the Market
• February 2018 – Merck Launched Viresolve Barrier Capsule Filters to Protect Against Bioreactor Contamination
Major players – MERCK KGAA, CHARLES RIVER LABORATORIES INTERNATIONAL, BIOMERIEUX SA, SGS S.A., SARTORIUS AG, WUXI APPTEC, AND THERMO FISHER SCIENTIFIC, amongst others.
Reasons to Purchase this Report
• Current and future sterility testing market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increase in the Number of New Drug Launches
6.1.2 Increasing R&D in Life Science Research
6.1.3 Rise in Demand for Sterilized Products and their Exclusivity in the Healthcare Industry
6.2 Market Restraints
6.2.1 High Degree of Market Consolidation
6.2.2 Stringent Regulatory Framework
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type of Products
7.1.1 Kits and Reagents
7.1.2 Instruments
7.1.3 Services
7.2 By Test Type
7.2.1 Membrane Filtration
7.2.2 Direct Inoculation
7.2.3 Other Sterility Tests
7.3 By Application
7.3.1 Pharmaceutical and Biological Manufacturing
7.3.2 Medical Devices Manufacturing
7.3.3 Other Applications
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United Kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific
7.4.3.1 China
7.4.3.2 Japan
7.4.3.3 India
7.4.3.4 Australia & New Zealand
7.4.3.5 South Korea
7.4.3.6 Rest of Asia-Pacific
7.4.4 Middle East & Africa
7.4.4.1 GCC
7.4.4.2 South Africa
7.4.4.3 Rest of the Middle East & Africa
7.4.5 South America
7.4.5.1 Brazil
7.4.5.2 Argentina
7.4.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 BioMerieux SA
9.2 Charles River Laboratories International
9.3 Merck KGaA
9.4 Sartorius AG
9.5 SGS S.A.
9.6 Danaher Corporation
9.7 Nelson Laboratories
9.8 Thermo Fisher Scientific
9.9 Toxikon Corporation
9.10 WuXi AppTec
9.11 List Not Exhaustive
10. Future of the Market